Get started
Author

Carlos Aguilar-Franco

Observed names: C. Aguilar-Franco, Carlos Aguilar, Carlos Aguilar‐Franco
ORCID: 0000-0002-5225-6687
Observed ORCID: 0000-0002-5225-6687
OpenAlex ID: A5047265431
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy
2019 · Luzalba Sanoja-Flores, Juan Flores-Montero, et al. · Blood · 110
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma
2023 · Borja Puertas, Verónica González-Calle, et al. · Cancers · 93
PDF
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
2024 · Tomás José González-López, Nuria Bermejo-Vega, et al. · Blood · 52
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma
2024 · Marta Lasa, Laura Notarfranchi, et al. · Journal of Clinical Oncology · 20
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study
2025 · Lucía Pérez-Lamas, Adrián Segura Diaz, et al. · Blood Cancer Journal · 13
PDF
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients
2021 · Robéria Mendonça de Pontes, Juan Flores-Montero, et al. · Cancers · 10
Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency
2025 · Pablo García-Jaén, José Manuel Martín de Bustamante, et al. · Thrombosis and Haemostasis · 1
Ending the undetermined significance of monoclonal gammopathies (MGUS): First results of the nomoremgus study
2025 · Marta Lasa, Esperanza Martin-Sanchez, et al. · Blood · 1
PDF
The mutational landscape of resistance to BTK and BCL2 inhibitors in CLL: a real-world multicentric study
2026 · Miguel Bastos-Boente, María García-Álvarez, et al. · Blood Cancer Journal
PDF
Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival
2026 · Borja Puertas, Irene Padilla, et al. · British Journal of Haematology
PDF
Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation
2025 · Borja Puertas, Elena Alejo, et al. · Clinical Lymphoma Myeloma & Leukemia
PDF
Acute Myeloid Leukemia: Diagnosis and treatment at a tertiary center in cochabamba - Bolivia.
2025 · Veronica Campuzano Saavedra, Cristian Rodrigo Lazo, et al. · Blood
PDF
Molecular predictors of anemia response to momelotinib in patients with myelofibrosis: Real-world outcomes from the momgemfin study.
2025 · Adrian Segura Diaz, Lucia Perez Lamas, et al. · Blood
P-182 Impact of Minimal Residual Disease in Apheresis Product (aMRD) Assessed by Multiparametric Flow Cytometry (MFC) in Transplant-Eligible Multiple Myeloma (MM) Patients
2024 · Borja Puertas, Elena Alejo, et al. · Clinical Lymphoma Myeloma & Leukemia
P-183 Monoclonal Gammopathy of Uncertain Significance (MGUS) Like Profile in Transplant-Eligible Multiple Myeloma (MM) Patients: Clinic-Biological Characteristics and Prognosis Significance
2024 · Borja Puertas, Elena Alejo, et al. · Clinical Lymphoma Myeloma & Leukemia
Pf357 a Novel Refined Prognostic Model for Chronic Lymphocytic Leukemia Patients Combining Igh Translocations and Next-generation Sequencing
2019 · C. Pérez-Carretero, M. Hernández-Sánchez, et al. · HemaSphere
Works count: 16
Citation count: 300
H-index: 6
I10-index: 6
Year
Topic
Type